Principal Technologies (TSXV:PTEC) ROCE %: 0.00% (As of Jan. 2026)


TSXV:PTEC Principal Technologies Inc TSXV:PTEC
22 GF Score
Price C$0.38
GF Value C$0.03
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Principal Technologies ROCE %?

Principal Technologies TSXV:PTEC 22 ROCE % is 0.00% as of Jan. 2026. GuruFocus rates TSXV:PTEC with a GF Score™ of 22/100 and a GF Value™ of C$0.03 (Significantly Overvalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Principal Technologies's annualized ROCE % for the quarter that ended in Jan. 2026 was 0.00%.

Principal Technologies  (TSXV:PTEC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Principal Technologies ROCE % Related Terms

Principal Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Principal Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Principal Technologies ROCE % Chart

Principal Technologies Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROCE %
Get a 7-Day Free Trial -29.68 -138.84 -264.57 -243.51 -702.18

Principal Technologies Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -274.14 -793.31 -1,238.22 0.00 0.00
TSXV:PTEC
22GF Score
Principal Technologies Inc TSXV:PTEC
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Principal Technologies ROCE % Calculation

Principal Technologies's annualized ROCE % for the fiscal year that ended in Jul. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2025 )  (A: Jul. 2024 )(A: Jul. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2025 )  (A: Jul. 2024 )(A: Jul. 2025 )
=-4.185/( ( (1.51 - 0.519) + (1.546 - 1.345) )/ 2 )
=-4.185/( (0.991+0.201)/ 2 )
=-4.185/0.596
=-702.18 %

Principal Technologies's ROCE % of for the quarter that ended in Jan. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jan. 2026 )  (Q: Oct. 2025 )(Q: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jan. 2026 )  (Q: Oct. 2025 )(Q: Jan. 2026 )
=-6.072/( ( (0.96 - 1.568) + (0.87 - 1.317) )/ 2 )
=-6.072/( ( -0.608 + -0.447 )/ 2 )
=-6.072/-0.5275
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Principal Technologies (TSXV:PTEC) has a ROCE % of 0.00% as of Jan. 2026.
Is Principal Technologies' ROCE % too high?
Principal Technologies' current ROCE % is 0.00%. Overall, Principal Technologies has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Principal Technologies' ROCE % compare to VEEV and BTSG?
Principal Technologies' ROCE % of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Principal Technologies's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Principal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Principal Technologies (TSXV:PTEC) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.03, compared to a current price of C$0.38 — trading 1166.7% above its estimated fair value. The current ROCE % is 0.00%. Principal Technologies' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Principal Technologies (TSXV:PTEC), the current ROCE % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Principal Technologies (TSXV:PTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Principal Technologies stock appears to be overvalued. The current stock price of C$0.38 is trading 1166.7% above its estimated GF Value™ of C$0.03. GuruFocus considers Principal Technologies to be Significantly Overvalued.

Key valuation signals for TSXV:PTEC:

  • ROCE %: 0.00%
  • GF Value™: C$0.03 vs. price of C$0.38 (1166.7% above fair value)
  • GF Score™: 22/100 with 7 warning signs

No single metric tells the full story. See the TSXV:PTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Principal Technologies Business Description

Other Exchanges JO7:Germany
Address 700 West Georgia Street, Suite 2500, Vancouver, BC, CAN, V7Y 1B3
Principal Technologies Inc is in the research and development stage of building a portfolio of medical technology assets with a focus on distribution potential and intellectual property capable of enhancing medical treatment, cost efficiency, and optimization of the patient pathway. The company focuses on acquiring medical technology research and development assets or developing them jointly with industry leaders. Its current revenue-generating activities are attributable to E&E CRO Consulting GmbH, which provides clinical research advisory services. The company operates in one reportable operational segment, consisting of project management of clinical studies and research related to medical device technologies.
22GF Score

Get the complete analysis for TSXV:PTEC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.38
Price
C$0.03
GF Value